about
Iduronate 2-sulfataseHeparan sulfate proteoglycan 2Hyaluronidase 2Glypican 4Glypican 1Glypican 3Glypican 5Glypican 2Glypican 6Hyaluronidase 4Heparanase 2 (inactive)Lymphatic vessel endothelial hyaluronan receptor 1Syndecan 3Syndecan 4Syndecan 2Galactosidase beta 1Alpha-L-iduronidaseN-sulfoglucosamine sulfohydrolaseAlpha-L-iduronidaseLymphatic vessel endothelial hyaluronan receptor 1Hyaluronoglucosaminidase 2Glucuronidase betaN-acetyl-alpha-glucosaminidaseChondroitinase BT_3324Chondroitinase BT_3350Alpha-L-iduronidaseHyaluronidase 4Alpha-L-fucosidase Dmel_CG6128N-sulfoglucosamine sulfohydrolase Dmel_CG14291N-sulfoglucosamine sulfohydrolase (sulfamidase)Heparan-alpha-glucosaminide N-acetyltransferaseSyndecan 1AgrinAlpha-L-fucosidase 1Hyaluronidase 2N-sulfoglucosamine sulfohydrolaseGlucosamine (N-acetyl)-6-sulfataseHeparanase
P682
Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic propertiesHYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificityInsights into Hunter syndrome from the structure of iduronate-2-sulfatase
P921
Q14880367-CD15CEC9-CA26-4DD2-ADB3-58F286998363Q14888022-3F477D59-8992-426D-8D12-E1DB8C60D1E3Q14905005-451AA3B0-90BD-4B47-A9AD-98643D1802FBQ21119951-1638B614-5534-4E6D-9635-85D3A42265C1Q21173785-157AB193-7553-4682-9F24-45BAFBF52DCAQ22276150-273C21AB-E7A8-421A-BC74-A9102E4D0C89Q22276157-B79CF0B1-5E19-4C4D-89FB-83B4AF4FF209
P279
Q10814203-94806FD8-6590-4FAB-AC4A-D9B17D80496BQ2071346-880EC666-11CB-4974-8FAB-93DA2EB7CA08Q21103082-7A22420E-21B9-41F8-B538-919003F6192FQ21103178-3D3B20F2-4D63-422C-93EA-0C6B842B9484Q21103189-779652B8-C1FE-48FF-8A9C-378A91FB80ACQ21103196-18783ADC-9CC7-42A6-ADA6-796024594B99Q21103197-32391164-1583-49D6-AB64-3411F7310E68Q21103199-BC70AF8D-5CCF-4A50-8FDA-2D901D16B71CQ21103213-ADB60D38-D1F9-4C7B-8705-B26062878FBBQ21118412-E68F45E7-B554-4F6A-84E9-FFC714793908Q21119764-5633FB12-5268-4602-A90A-6CC783DEDB8CQ21120734-07B654E3-45ED-443D-9471-642DD41C40BAQ21127159-34A3BFDE-3839-4547-9A6D-2766745E833AQ21132683-A0A02D07-1D89-4741-8676-B4D6405A75D4Q21132959-2783D473-B9E1-4845-B964-E3CCC6C1C8F8Q21173663-147A8945-C777-4550-873E-C3F010CDB97FQ21173788-59BDEC0D-A660-49BA-B2A8-BDC99CEED5C9Q21173832-64960809-55FE-4862-B36C-99D0251E30EAQ21173832-840E5CDC-C651-4F1D-AB1F-11BA32658DCCQ21496504-4F90DA90-6811-4BEF-B886-EC47635A1DD7Q21496504-6C2AA4C4-A07B-4464-9722-3F07144C6ECDQ21496579-BD64846F-7DF8-427A-8311-745A44530B3BQ21984507-1EBF5D14-64C5-4D57-80DA-459EF606860FQ22677398-4CB85AB5-E6F5-4BB2-AF5E-3E0FE399961CQ22678008-AFBA8CC1-E162-4304-941C-6CE207477F34Q23455179-6673BFAD-746C-46FC-BC22-B9AD1B2AAA24Q23456629-97722DF2-6BE0-4531-AD94-7C8D0DC3681DQ29520064-DC076A66-4B79-4CDB-8C6B-2CF675446F63Q29526006-C8C0F19D-C285-43A9-A549-7161FA557523Q29809472-8DBE8474-6F43-47B2-9FBE-7111FC435700Q29814506-968F9220-1E6A-4C62-847A-6CDE95CE15EAQ29824108-6B0ACF15-0542-484D-98BA-4F440BACB8C0Q3726754-477E7601-FDAC-43A2-B675-B06633B8288BQ4420082-034D37C0-A26B-4F07-81FF-62A90EF47BA7Q4694120-24FE93E1-E991-4EE5-A42B-D13CEAAB0C8AQ5507033-4EBBEEE2-1B86-475A-8CD4-3886AEAD90ECQ55202463-0979ACB5-979C-4AC1-BC1B-300D0059278CQ55203180-5A7C96EB-49CB-4B04-99DC-F6FFE45B084DQ6951427-BCBC769D-06A0-4EF0-9146-705E7C7E9E50Q909646-A4EC7983-6580-42CB-85BC-D7AC7F65C6F3
P682
description
The chemical reactions and pat ...... des that contain amino sugars.
@en
biologisch proces
@nl
name
glycosaminoglycan catabolic process
@en
type
label
glycosaminoglycan catabolic process
@en
altLabel
GO:0006027
@en
glycosaminoglycan breakdown
@en
glycosaminoglycan catabolism
@en
glycosaminoglycan degradation
@en
prefLabel
glycosaminoglycan catabolic process
@en
P2888
P686
GO:0006027